ALKBH5 and nonpapillary renal cell carcinoma: Like ALKBH5, FTO is downregulated as a tumor suppressor in a variety of cancers, including BC (145), lung cancer (212), CRC (213), bladder cancer (214, 215), prostate cancer (216), ccRCC (181, 217, 218), and adrenocortical cancer (219).